People of European and African ancestries who were hospitalized for COVID-19 are more likely to carry a particular combination of genetic variants in a gene known as OAS1 than patients with mild disease who were not hospitalized.
An FDA vaccine advisory committee recommended future COVID-19 vaccine boosters should include a SARS-CoV-2 omicron BA.4/5 component for boosters beginning in fall 2022.
No one has a crystal ball to see which SARS-CoV-2 variant will come next or how good future variants will be at evading vaccine immunity. But looking to other respiratory viral foes that have troubled humanity for a while can suggest what the future could look like.
NSAIDs will not worsen the condition of COVID-19 patients or impact outcomes, a systematic review found.
Read More
According to ARRS’ American Journal of Roentgenology, axillary lymphadenopathy detected by breast ultrasound after COVID-19 mRNA vaccination lasts longer than reported in initial vaccine clinical trials.
Read More
Even though demand for COVID-19 tests greatly overwhelmed supply earlier in the pandemic, rapid home tests are more available today.
Read More
Patients with severe COVID-19 who were treated with imatinib had lower mortality rates at 90-day follow-up, according to research presented at ATS 2022.
Read More
The health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in a new study in the peer-reviewed Journal of Medical Economics.
Read More
For patients discharged after hospitalization for COVID-19, death or readmission was common, with about 11% being readmitted or dying within 30 days, according to new research.
Read More
As MIS-C rates rose, physicians began to note its similarities to a pre-pandemic illness, Kawasaki disease, which has puzzled pediatricians for more than 50 years.
Read More
Researchers investigated how cancer patients faired when faced with COVID-19 infections. Results were published online in PLOS ONE.
Read More
University of California, San Francisco, researchers are following volunteers who’ve recovered from COVID-19, collecting blood and saliva samples at regular intervals to monitor changes in antibody levels.
Read More
While COVID vaccine-induced neutralizing antibody responses protect against SARS-CoV-2 infection, control of viral replication is mediated by responses that involve T cells and the antibody-binding Fc receptor.
Read More
The FDA says it is “aware” of counterfeit home COVID tests being distributed or used in the US and warns consumers to be on the lookout.
Read More
While rapid antigen COVID tests remain a useful tool for the detection of COVID-19 infections, continuous assessment and updating is likely needed in the context of variants of concern.
Read More